Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 1776
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
weasel667
08/06/2025 10:25:44 AM
Hey guys, what's with all the cryptic
(9)
docj
08/06/2025 10:24:05 AM
Yeah, I don't get it. All this is way
(6)
hoops
08/06/2025 7:28:22 AM
Hey guys, what's with all the cryptic
(24)
KenChowder
08/06/2025 3:39:11 AM
Expecting one very soon and please
(7)
Katangolo
08/06/2025 1:42:30 AM
Im on it, Shelly. Thanks for lurking
Shelly2626
08/05/2025 10:32:23 PM
Ok ....its time to get a big boom GLTA
(5)
Buddyboy20
08/05/2025 9:49:07 PM
Have Japanese researchers stumbled on a
(2)
brentie
08/05/2025 9:19:54 PM
Thanks for posting that, docj. I was
(16)
docj
08/05/2025 3:52:26 PM
https://d1io3yog0oux5.cloudfront.net/_c
(13)
My69z
08/05/2025 10:19:11 AM
"2nd opinion" ---- Imagine having been
(4)
My69z
08/05/2025 9:51:54 AM
"....we are excited to explore
(7)
My69z
08/05/2025 9:45:41 AM
& inventory into LL is what the recent
(1)
Katangolo
08/05/2025 9:23:46 AM
We were also told several years ago
(5)
hoops
08/05/2025 8:26:52 AM
Has this been posted previously? Has
(3)
Mr3Putt
08/05/2025 8:21:50 AM
Whilst we await whatever the bioscience
(5)
My69z
08/04/2025 7:31:31 PM
"The decline in circulating tumor cells
(17)
My69z
08/04/2025 7:10:20 PM
Science updated:
(16)
Mr3Putt
08/04/2025 3:02:10 PM
UWS on the murkiness of Merck:
(1)
rodolfo
08/04/2025 2:45:16 PM
The german H.Q. is in Darmstadt and in
(2)
Evil Rabbit
08/04/2025 12:55:20 PM
Well, if we've had an arrangement with
(5)
Ganesha
08/04/2025 12:31:50 PM
Well, if we've had an arrangement with
(17)
BuckCYDYLong
08/03/2025 10:30:44 AM
"Merck is investing heavily in its
docj
08/03/2025 8:12:07 AM
Thanks. I posted UWS's take on IHUB.
(2)
biloxiblues
08/03/2025 7:25:27 AM
From Reddit Final Thoughts on the
(5)
KenChowder
08/02/2025 8:55:17 AM
There was an infamous Mayor of
(2)
HouseofCards
08/02/2025 12:07:50 AM
So, according to UWS on r/Livimmune,
(3)
sean007
08/01/2025 9:20:49 PM
Our lease on Main St. ends April
(3)
Evil Rabbit
08/01/2025 8:49:12 PM
Thanks Wax. Ive been out all day so
(8)
misiu143
08/01/2025 2:19:35 PM
She has stage 4 Malignant Melanoma ,
(12)
sean007
08/01/2025 1:01:10 PM
They are making funeral plans...what a
(4)
sean007
08/01/2025 12:59:33 PM
John Mellencamps daughter Teddi
(1)
waxonwaxoff
08/01/2025 12:44:33 PM
Thanks Gambler. Truly an exercise in
(11)
HHIGambler
08/01/2025 12:37:15 PM
On behalf of the IHang team and those
(14)
waxonwaxoff
08/01/2025 12:27:10 PM
Banned from r/Livimmune last night
(3)
cardamine
07/31/2025 8:55:33 PM
(I did NOT mean an emoji! I meant to
(4)
cardamine
07/31/2025 7:52:12 PM
(fwiw: "While specific adverse event
(3)
Figgs
07/31/2025 2:27:06 PM
Could Leronlimab be used as a longevity
(5)
Evil Rabbit
07/31/2025 1:18:01 PM
Hey Riz (NOMOD), Youve been told by
(26)
dfwl28
07/31/2025 12:46:45 PM
IL-6 cytokine -slow day "...Unlike
enemyofpluto
07/30/2025 8:55:53 PM
1,750 million IS 1.75B.
(7)
bbqbbq
07/30/2025 7:23:49 PM
Garry Nolan's role with the CCR5
(6)
misiu143
07/30/2025 3:54:40 PM
It is not always easy , her doctor in a
(8)
ohm20
07/30/2025 3:48:55 PM
Dr Jay do not give RTT or
(11)
misiu143
07/30/2025 3:34:38 PM
Not always that easy to get IRB. Friend
(5)
sean007
07/30/2025 3:29:10 PM
The FDA approves over 99% of ALL
(12)
misiu143
07/30/2025 2:00:30 PM
Dr Jay do not give RTT or
(16)
NOMOD
07/30/2025 9:10:47 AM
Youre very welcome. Youre doing
(7)
cardamine
07/30/2025 1:30:00 AM
Thank you for writing all this out--it
(3)
NOMOD
07/30/2025 1:08:21 AM
I cant PM, so feel free to email me
(20)
cardamine
07/30/2025 12:50:56 AM
Quick Question re right to
(5)
Newer
Older
Recent Articles
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy
Aalberts N.V. Strengthens Position with GVT Acquisition
Nxera Pharma's Innovations and Financial Report for 2025
Nxera Pharma Expands Manufacturing to Meet Growing Demand for QUVIVIQ®
Vistin Pharma Reports Strong Q3 Results and Market Growth
Corbus Pharmaceuticals Sets Price for New Stock Offering
Introducing a New Executive Team Member at Realkredit Danmark
Aalberts Enhances Market Position Through Latest Acquisition
Exploring the Future of Green Hydrogen Development
Aker Solutions ASA Sees Revenue Boost in Third Quarter
Aker Solutions Reports Strong Performance in Q3 2025
Aker Solutions’ Record Growth and Promising Future Outlook
Investigation Launched into Conduent's Major Data Breach Event
Vallourec Secures Groundbreaking Contract for Deepwater Project
Essential Patient Inquiries for Portable X-Ray Scheduling
Exploring Affordable Coastal Living Alternatives Near Beaches
Intensity Therapeutics Sees Dip After Surging to New Heights
Marimekko's Strategic Growth and Operations in 2025
SCOR Reports Impressive Q3 2025 Earnings and Growth Metrics
SPIE Reports Robust Growth and Strategic Acquisitions in 2025
Trifork Group Achieves 4.7% Revenue Growth in Q3 Growth Report
Ekspress Grupp’s Revenue Growth and Future Strategies Unveiled
Marimekko Sees Growth in Q3 Revenue and Profits for 2025
Syensqo's Strategic Shift: Selling Oil & Gas Division to SNF
Elis Expands its Reach in Germany with New Acquisition Deal
Biotalys' EVOCA Biofungicide Nears EPA Approval, Changing Crop Protection
Hyundai and NVIDIA Unite for Advanced AI Innovation
Transforming Manufacturing: NVIDIA and SK Group's AI Collaboration
NVIDIA and Samsung Launch Revolutionary AI Manufacturing Factory
NVIDIA and South Korea Join Forces to Revolutionize AI Landscape
Vallourec Secures Major Offshore Contract with TechnipFMC
SCOR Achieves Remarkable Q3 2025 with Strong Net Income
Realsee Partners with Linkhome to Transform Real Estate with AI
Revolutionizing Retirement: How Physicians Are Investing Wisely